beta-thujaplicinol has been researched along with lamivudine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Borrego, D; Clercq, E; Frutos-Beltrán, E; Gao, S; Kang, D; Liu, X; López-Carrobles, N; Menéndez-Arias, L; Pannecouque, C; Río, JMD; Wei, F; Xu, S; Zhan, P; Zhang, J; Zhang, L; Zhao, F | 1 |
Lomonosova, E; Tavis, JE; Zlotnick, A | 1 |
2 other study(ies) available for beta-thujaplicinol and lamivudine
Article | Year |
---|---|
Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitors.
Topics: Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonuclease H, Human Immunodeficiency Virus; Structure-Activity Relationship | 2022 |
Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
Topics: Allosteric Regulation; Antiviral Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Gene Expression; Hep G2 Cells; Hepatitis B virus; Humans; Isoquinolines; Kinetics; Lamivudine; Ribonuclease H; Tetrazolium Salts; Thiazoles; Tropolone; Viral Proteins; Virus Replication | 2017 |